��������

Nan Ji has a significant work experience in the biotech and pharmaceutical industry. Nan is currently the Co-Founder, President, and CEO of PAQ Therapeutics since June 2020. Before that, they worked at Kymera Therapeutics where they held various roles including Vice President, Head of Chemistry from January to June 2020, Executive Director, Head of Chemistry from February 2019 to January 2020, and Director of Chemistry from May 2017 to February 2019. Prior to Kymera Therapeutics, they worked at Mitobridge, Inc. as Associate Director from January 2016 to May 2017 and as a Senior Scientist from May 2015 to January 2016. Nan Ji also has experience with Novartis Institutes for BioMedical Research (NIBR) where they were an Investigator III from September 2012 to May 2015 and Investigator II from May 2008 to September 2012. Their earliest work experience was as a Postdoctoral Fellow at Harvard University from October 2006 to April 2008.

Nan Ji pursued a Bachelor's degree in Organic Chemistry from Peking University from 1996 to 2000. Following this, they attended Harvard University from 2000 to 2006, where they obtained a Ph.D. in Organic Chemistry.